TF
BRLI

Tompkins Financial’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Tompkins Financial’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,217
Closed -$37K – 536
2014
Q2 		$37K Hold
1,217
– – 0.01% 305
2014
Q1 		$34K Hold
1,217
– – 0.01% 315
2013
Q4 		$31K Buy
1,217
+145
+14% +$4.47K 0.01% 323
2013
Q3 		$32K Hold
1,072
– – 0.01% 309
2013
Q2 		$31K Buy
+1,072
New +$29.5K 0.01% 310

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Tompkins Financial's BRLI Position: Q3 2014 in Review

Tompkins Financial sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2014, closing a stake of 1,217 shares — an estimated $37K sold.

Tompkins Financial first reported a position in BRLI in Q2 2013 and held it in 5 quarters. The position peaked at $37K in Q2 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q3 2014.

  • Tompkins Financial reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2014 after selling out during the quarter.
  • Tompkins Financial sold 1,217 BIO-REFERENCE LABS INC-NEW- shares in Q3 2014, an estimated $37K.
  • Tompkins Financial first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 5 quarters.
  • Tompkins Financial's BIO-REFERENCE LABS INC-NEW- position peaked at $37K in Q2 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2014.

Based on Tompkins Financial's 13F filing for Q3 2014, filed 10 Oct 2014.